Overview

Nishant is a Partner at Luthra and Luthra Law Offices India and specializes in the area of Mergers & Acquisitions, Private Equity & Venture Capital and Banking & Finance.

Nishant is admitted to practice law in India and the State of New York (USA). In the last 19 years, Nishant has worked on a wide array of equity and debt financing transactions across multiple sectors and countries. In the M&A space, he has worked on listed as well as unlisted company transactions including, public takeover, PIPE, going private, JV and minority or majority equity investments. As regards the debt investment, he advises on structured debt funding and re-structuring transactions.

Nishant also advises corporate houses and HNI’s in relation to investigations by government agencies like Serious Fraud Investigation Office, Central Bureau of Investigation, Enforcement Directorate, Economic Offence Wing for charges of bribery, money laundering, corporate fraud and various other offences and assists clients in formation of internal corporate policies and structures against anti-bribery, anti-corruption, anti-corporate fraud, whistleblowing, anti-sexual harassment, data privacy and cyber security.

His past international experience of working with the top tier law firms in San Francisco, New York and London offers his clients a distinctive approach and expertise on cross-border deals.

Experience Statement

• Advised American International Group Inc. in its sale of American Life Insurance Corporation to MetLife Inc. for USD 15.5 Billion.
• Advised Future Group, in relation to USD 5 Billion debt re-structuring of Future Retail Limited, Future Enterprises Limited, Future Lifestyle Fashions Limited, Future Consumer Limited, Future Supply Chain Solutions Limited, and other unlisted companies for all outstanding debt owed to 28 Indian banks-consortium under the resolution framework for COVID-19-related stress announced by the Reserve Bank of India.
• Advised Novo Holdings A/S to acquire majority stake in Manipal Health Enterprises for USD 3.6 Billion alongside investors Temasek, The California Public Employees’ Retirement System (CalPERS) and TPG Asia.
  • The transaction is a part of the largest private equity deal in the Indian healthcare sector.
• Represented Pocket Aces Pictures Private Limited, through its board of directors (‘Pocket Aces’), and its founders, Aditi Shrivastava, Ashwin Suresh and Anirudh Pandita, in relation to its acquisition by Saregama India Limited (‘Saregama’), a subsidiary of RP-Sanjiv Goenka (RPSG) Group. Saregama will initially acquire 51.8% shares in Pocket Aces, with the subsequent acquisition of another ~41% stake in next 15 months at pre-agreed multiples. The transaction is an all-cash deal.
  • The deal was listed as one of the top 10 mergers and acquisitions deals.
• Advised Orange S.A., a listed company, in relation to its acquisition of Bharti Airtel Limited’s (a listed company) offshore subsidiaries in two African countries (Burkina Faso and Sierra Leone) for approx. USD 1 Billion.
• Advised Agritrade Resources Ltd., a listed company on the Hong Kong Stock Exchange, in relation to acquisition of SKS Power Generation (Chhattisgarh) Limited through a One Time Settlement of USD 350 Million approx.for all outstanding debt to State Bank of India, L&T Infrastructure Finance Company Limited and PTC (India) Financial Services Limited.
• Advised Engie Solar SAS and Electro Solaire Private Limited, in a project financing for an amount of USD 100 Million approx.availed from the Asian Development Bank and Société Générale for setting up a 2x 100MW AC grid-connected solar PV project in Raghanesda Solar Park, Gujarat.
• Advised IndoStar Capital Finance, a listed company, in relation to Brookfield Asset Management’s acquisition of 40% stake for INR 1225 Crore through a mix of primary and secondary shares from Everstone Capital, infusion of capital in IndoStar Capital Finance, and public shareholders under the Takeover Code.
• Advised Cipla Limited, in relation to its acquisition of brand rights to market derma and cosmeceutical products manufactured by Percos India.
• Advised Reliance Jio, in relation to its acquisition of properties related to telecom towers from Reliance Communications.
• Advised NewQuest Capital Partners, in relation to its acquisition of a minority stake in Kids Clinic India Private Limited (operating as Cloudnine chain of hospitals), through a combination of a primary investment and acquisition of secondary stake from existing investors and other shareholders in Cloudnine.
• Advised Pharmarack Technologies, in relation to its 92% acquisition by ABCD Technologies LLP, a digital health firm backed by Sun Pharma, Lupin, Cadilla Healthcare and Torrent.